Nagaland Breakthrough: Natural Compound Reveals New Hope for Diabetic Wounds

Researchers at Nagaland University have made a groundbreaking discovery in diabetic wound care. They identified Sinapic acid, a natural plant compound, as highly effective for accelerating wound healing in diabetic conditions. This marks the first global study demonstrating that oral administration of this compound can significantly improve tissue repair through SIRT1 pathway activation. The findings offer hope for safer, more affordable treatments that could reduce amputation risks for millions of diabetes patients worldwide.

Key Points: Nagaland University Sinapic Acid Diabetic Wound Healing Discovery

  • First global study showing oral Sinapic acid accelerates diabetic wound healing
  • Compound activates SIRT1 pathway for tissue repair and angiogenesis
  • Lower 20 mg/kg dose proved more effective than higher dose
  • Research collaboration between Nagaland University and Lovely Professional University
  • Published in Nature Scientific Reports with international credibility
  • Focuses on affordable natural therapy for rural healthcare settings
3 min read

Nagaland University study identifies natural compound with potential for Diabetic treatment

Nagaland University researchers identify Sinapic acid as powerful natural treatment for diabetic wound healing, accelerating recovery and reducing amputation risk through SIRT1 pathway activation.

"This discovery not only highlights the strength of our scientific community but also reflects our commitment to addressing pressing health challenges through innovation rooted in nature. - Prof. Jagadish K. Patnaik, Vice Chancellor, Nagaland University"

Kohima, October 21

Nagaland University researchers have identified a naturally occurring plant compound called 'Sinapic acid' as a powerful therapeutic agent capable of significantly accelerating wound healing in diabetic conditions.

The discovery marks a major advancement that could result in safe, natural, and effective treatments for diabetic wound management.

According to the release, this is the first study globally to demonstrate that Sinapic acid, when administered orally, can accelerate diabetic wound healing in preclinical models. The research established that the compound works by activating the SIRT1 pathway, which plays a crucial role in tissue repair, angiogenesis, and inflammation control.

The multidisciplinary study involved collaboration between experts from Nagaland University and Lovely Professional University (LPU), Punjab, combining expertise in biotechnology, pharmacology, biochemistry, and medical laboratory sciences, as stated in the release.

The release further mentioned that Prof. Pranav Kumar Prabhakar, Department of Biotechnology, School of Engineering and Technology, Nagaland University, led research. It included Rupal Dubey, Sourbh Suren Garg, Navneet Khurana and Jeena Gupta from Lovely Professional University.

The findings have been published in Nature Scientific Reports (DOI: https://doi.org/10.1038/s41598-025-03890-z), a peer-reviewed, open-access journal from Nature Portfolio (Springer Nature), lending strong international credibility to this work.

Highlighting the real-world impact of this Research, Prof. Jagadish K. Patnaik, Vice Chancellor, Nagaland University, said, "I am delighted to share that a study conducted by our researchers at Nagaland University has identified a natural compound with remarkable potential in the treatment of diabetic wounds. This discovery not only highlights the strength of our scientific community but also reflects our commitment to addressing pressing health challenges through innovation rooted in nature. I congratulate the research team for their dedication and contribution towards improving healthcare solutions."

Elaborating on how this research addresses a Critical Global Health Challenge, Prof. Pranav Kumar Prabhakar, Head, Department of Biotechnology, School of Engineering and Technology, Nagaland University, said, "Diabetes mellitus remains one of the world's most pressing chronic diseases, affecting hundreds of millions globally. Among its serious complications is delayed wound healing, often resulting in diabetic foot ulcers, infection, and, in severe cases, amputation. Existing synthetic drugs have shown limited efficacy and often cause undesirable side effects."

Prof. Pranav Kumar Prabhakar added, "We set out seeking a safe, plant-based alternative -- exploring how Sinapic acid, a naturally occurring antioxidant found in various edible plants, could accelerate tissue repair, reduce inflammation, and promote new blood vessel formation in diabetic wounds. We found that a lower dose (20 mg/kg) was more effective than a higher one (40 mg/kg), a phenomenon known as 'Inverted Dose-Response.' This result not only optimises dosage strategy but also has significant clinical implications for future drug development."

The key implications of this discovery include reducing the risk of amputation and accelerating recovery in diabetic foot ulcers and providing an affordable, natural oral therapy, improving accessibility for patients in rural and resource-limited settings.

The next phase will focus on translating this success into real-world therapeutics through - Detailed molecular pathway studies (PI3K/Akt, NF-kB), Toxicity and pharmacokinetic profiling to ensure safety, Formulation development for capsules or nutraceutical tablets, Pilot clinical trials in diabetic patients to test efficacy and safety.

- ANI

Share this article:

Reader Comments

R
Rohit P
Great to see Indian universities making such significant contributions to medical science. Nagaland University and LPU collaboration shows the power of teamwork in research. More funding should go to such institutions!
D
David E
As someone working in pharmaceutical research, I'm impressed by the scientific rigor. Publication in Nature Scientific Reports is no small feat. The inverted dose-response finding is particularly interesting from a clinical perspective.
A
Ananya R
The affordability aspect is crucial for India where diabetes is becoming an epidemic. If this can reach rural patients at reasonable costs, it could save countless limbs and lives. Hope the clinical trials proceed quickly! 💪
S
Sarah B
While this is exciting research, I hope the government ensures that the benefits reach common people and aren't just commercialized by big pharma companies. We've seen promising Indian research get patented abroad before.
V
Vikram M
Traditional medicine has always used plant-based remedies. Good to see modern science validating what our ancestors knew. Hope this leads to more research on Indian medicinal plants! 🌿
K
Kavya N
My uncle lost his leg to diabetes complications last year. Reading this gives me mixed feelings - happy that future patients might be saved, but sad that it didn't come sooner. Still, brilliant work by the research team!

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50